Clinical Trials Directory

Trials / Completed

CompletedNCT04038060

The PrEP (Pre-exposure Prophylaxis) SMART Study

Evaluation of Stepped PrEP (Pre-exposure Prophylaxis) Adherence Support for Young South African Women Using a SMART Design

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
350 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

The PrEP SMART study is testing a stepped model of scalable adherence support strategies in South African young women who initiate PrEP using a SMART (sequential multiple assignment randomized trial) design.

Detailed description

Women enrolled in the study will be randomized to standard of care adherence support (brief counseling) and either WhatsApp groups or weekly two-way SMS messages. Two months after PrEP initiation, tenofovir drug levels will be measured to determine if participants have achieved high adherence based on their initial randomization. Women with high adherence (i.e., TFV-DP \>/=500 fmol/punch from dried blood spots \[DBS\]) will continue with the adherence support to which they were initially randomized. Participants with low adherence (i.e., TFV-DP \<500 fmol/punch from DBS) will continue initial randomization (WhatsApp or two-way SMS) plus be randomized to more one of two more intensive adherence support interventions - continued monthly visits with adherence and problem-focused counseling at months 3-8 or quarterly visits between months 3-9 with feedback about adherence based on drug levels at months 3 and 6.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWhatsApp GroupParticipants will receive peer adherence support through WhatsApp groups
BEHAVIORAL2-way SMSParticipants will receive healthcare worker adherence support through 2-way SMS
BEHAVIORALDrug level feedbackParticipants will receive adherence counseling based on tenofovir drug levels
BEHAVIORALMonthly counseling sessionsParticipants will receive monthly counseling on a variety of issues that may be impacting their PrEP adherence

Timeline

Start date
2019-05-16
Primary completion
2021-10-27
Completion
2022-01-25
First posted
2019-07-30
Last updated
2023-09-01

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT04038060. Inclusion in this directory is not an endorsement.